PharmTech spoke with Ian Bilodeau, managing director, Ardena US about how the expanded use of AI has impacted the ...

Remco Munnik, Arcana, details pharma's shift to data-first operations, AI adoption, and robust data stewardship.

In late December 2025, Charles Ross & Son promoted its five-cubic-foot double cone tumbler blender for small- to mid-scale ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

The third and final portion of Bryant’s exclusive video interview with PharmTech ® deals with the processes known as human-in ...

Felix Gonzalez, FounderNest, offers a data-driven view of where pharma consolidation is occurring, where capital is being deployed, and how regional M&A strategies differ.

Our data show that global pharma M&A is becoming more selective and strategically targeted. While North America remains the ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

Autonomy is not a binary option, Bryant said in the first part of this video interview with PharmTech ®, and can work in ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...